Internal Limiting Membrane Peeling for Large Macular Holes

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00190190
Collaborator
(none)
80
1
2
40
2

Study Details

Study Description

Brief Summary

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

Condition or Disease Intervention/Treatment Phase
  • Procedure: With Peeling of Limiting the Intern of the Retina
  • Procedure: Internal limiting membrane peeling
N/A

Detailed Description

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at three postoperative months is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Secondary objectives: - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. - Gain of ETDRS visual acuity in the third postoperative month.- Progression of cataract - Frequency of the complications.

Number of subjects and duration of the study: 80 patients older than 18 yo , presenting a macular hole > 400 µm, divided into two parallel groups will be included and followed up 3 months. The estimated total duration of the study is 27 months.

Statistical analysis: The percentages of success in the 2 groups will be compared by a Chi ² or Fisher exact test. The test Q of COCHRAN will be used to take into account the ordered character of the categories.

Intermediate Analysis: An intermediate analysis is envisaged. The procedure of adjustment of the risk of Lan and DeMets will be used.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.
Study Start Date :
Jan 1, 2005
Actual Primary Completion Date :
May 1, 2008
Actual Study Completion Date :
May 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

With Peeling of Limiting the Intern of the Retina

Procedure: With Peeling of Limiting the Intern of the Retina
With Peeling of Limiting the Intern of the Retina

Active Comparator: 2

Traditional Procedure Without Peeling of Limiting

Procedure: Internal limiting membrane peeling
Traditional Procedure Without Peeling of Limiting
Other Names:
  • Traditional Procedure Without Peeling of Limiting
  • Outcome Measures

    Primary Outcome Measures

    1. percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups [at 3 months]

    Secondary Outcome Measures

    1. Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. [at 3 months]

    2. Gain of ETDRS visual acuity in the third postoperative month [at 3 months]

    3. Progression of cataract [at 3 months]

    4. Frequency of the complications. [at 3 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age equal to or higher than 18 years

    • Patient presenting a TM idiopathic of stage 2, 3 or 4

    • Macular hole > 400 µm in diameter

    • Patient having been informed of the objectives and constraints of the study and having signed an informed consent

    Exclusion Criteria:
    • Patient age < 18 years.

    • Patient having a strong myopia of the operated eye: correction carried or optimal >6 dioptres

    • Patient MONOPHTHALMIA.

    • Patient pseudophakia presenting an "insufficient" plan capsular CRYTALLINE.

    • Patient presenting a cataract making impossible a good visualization of the bottom of eye.

    • Patient presenting an important opacification capsular.

    • Patient presenting an associated ocular pathology being able to interfere with the operation.

    • Patient presenting a TM already operated of the eye to include

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service d'Ophtalmolgie de l'Hôpital Lariboisière Paris France 75010

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Ramin TADAYONI, MD, Assistance Publique - Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00190190
    Other Study ID Numbers:
    • P040604
    • PS040604
    First Posted:
    Sep 19, 2005
    Last Update Posted:
    Jul 18, 2008
    Last Verified:
    Jul 1, 2007
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 18, 2008